Question and pathway assessment
Clarify what remains uncertain about classification, product code, applicable requirements, or a likely premarket route, and determine whether a 513(g) request can help.
FDA 513(G) REQUEST CONSULTING
FDA 513(g) Request Consulting
Get clearer regulatory information before your team commits to a classification assumption, development plan, or submission path that may be difficult to unwind.
Discuss your classification question →CLARITY BEFORE COMMITMENT
When the classification question changes the whole program, uncertainty is expensive.
A medical-device team can do good technical work and still lose time if it is building around the wrong regulatory assumption. A classification question can affect intended use, claims, testing, clinical evidence, quality planning, financing conversations, and the timeline to market. When the answer is unclear, the pressure to keep moving can turn a reasonable working assumption into an expensive constraint.
Qualira helps teams decide whether an FDA 513(g) request is the right way to get the information they need, prepare a focused request, and use the response to make the next regulatory decision with more confidence. The goal is not simply to send a question. It is to make sure the question is specific enough to be useful and connected to the real decisions your program must make next.
WHERE QUALIRA HELPS
Focused support for a classification question with real program consequences.
Device and market context
Organize the device description, intended use, technology, comparable products, and relevant facts so FDA can understand the decision behind the request.
Request development
Build a clear, disciplined package that frames the regulatory question without overreaching or leaving the reviewer to infer critical context.
Response and next-step strategy
Connect FDA's response to the work ahead, including pathway planning, evidence strategy, a Pre-Submission, a 510(k), or another focused regulatory action.
THE RIGHT QUESTION, AT THE RIGHT TIME
A 513(g) request is most useful when it can still change the work that follows.
A 513(g) request is not a substitute for a complete regulatory strategy. It does not remove the need to understand the device, its intended use, its technology, or the evidence that may eventually support market access. What it can do is provide useful regulatory information when a team needs a clearer basis for moving forward.
The strongest requests begin with a practical decision. A founder may need to understand whether a proposed device concept is likely to sit in a familiar classification landscape or require a more novel pathway discussion. A product team may be evaluating how a new technology, indication, or product configuration affects its regulatory planning. An investor or leadership team may need a more grounded view of the questions that could shape scope, timing, and budget before committing to a development plan.
Qualira helps turn those broad concerns into a focused regulatory question. That requires more than describing a product at a high level. The request needs enough context to make the issue intelligible, while keeping the team honest about what information it is actually seeking. Intended use, device features, comparable technologies, proposed claims, and existing regulatory history may all matter. The right emphasis depends on the question, not on a one-size-fits-all template.
That discipline matters because the response will only be as useful as the question allows. A broad request can produce a broad answer that leaves the original uncertainty in place. A well-framed request helps the team understand what FDA can reasonably address, what it must investigate internally, and whether a different engagement, such as a Pre-Submission, is a better next step.
WHAT A FOCUSED REVIEW CLARIFIES
Use the classification question to make a better program decision.
Teams rarely need an answer in isolation. They need to understand what the answer means for the device, the people doing the work, and the next milestone. Qualira brings regulatory, technical, clinical, and quality judgment into the same discussion so that a classification question does not become disconnected from the program it will shape.
Some teams need support from the earliest product definition. Others have already completed substantial development work and need an independent view before they lock in an intended use, test plan, investor timeline, or submission approach. The engagement should match the decision in front of the team and create a clearer path forward, not add another layer of paperwork.
Whether a 513(g) request is the right tool
A 513(g) request is valuable when FDA regulatory information can resolve an important uncertainty. Qualira helps distinguish that need from a question better answered through research, a Pre-Submission, or broader pathway planning.
What must be clear before the request
The team needs a coherent description of the device and the exact uncertainty it is trying to resolve. Reviewing intended use, features, comparable products, and available regulatory information early helps prevent an unfocused question.
What the response means for development
FDA's response should shape practical choices, not sit in a file. Qualira helps connect it to evidence planning, claims, risk decisions, quality needs, and the pathway the team should investigate next.
When to change course
A response can reveal that the original assumption needs refinement. That is useful information when it arrives early enough to protect the program. Qualira helps teams adjust the plan before disconnected work creates avoidable cost and delay.
A CONNECTED REGULATORY VIEW
Classification is not an administrative detail. It shapes the choices that follow.
Regulatory uncertainty often appears as a narrow question, but it rarely stays narrow. A classification assumption influences the intended use a team can credibly support, the evidence it should plan to develop, the specialists it needs, and the milestones it can responsibly promise. The farther those choices move ahead without a shared view of the regulatory path, the more difficult it becomes to bring the program back into alignment.
Qualira works with internal regulatory, engineering, clinical, quality, and leadership teams to make the dependencies visible. That can mean helping a new device program investigate its classification landscape before development activity accelerates. It can also mean reviewing a proposed request after a team has encountered conflicting signals in the available information and needs a disciplined way to decide what to ask next.
The value is experienced judgment around the decision, not a generic request package. Qualira helps teams frame the question, understand the limits of the response, and use the information to make a more coherent next move. That protects options while the program still has room to act.
Explore regulatory consulting →A USEFUL FIRST CONVERSATION
Bring the classification question that is making the next step uncertain.
What regulatory question is affecting our development plan, investment decision, or submission approach?
Do we have enough clarity on intended use, technology, and comparable products to ask FDA a useful question?
Would a 513(g) request give us the information we need, or would a Pre-Submission be more valuable?
How should the response change the pathway, evidence, quality, or timeline decisions we make next?
FREQUENTLY ASKED QUESTIONS
Frequently asked questions
What is an FDA 513(g) request?
A 513(g) request is a formal way to ask FDA for information about how a device may be regulated, including classification, applicable requirements, or the type of premarket submission that may apply. It can give a team useful direction, but it does not provide clearance, approval, or a final determination on the complete product strategy.
When is a 513(g) request useful?
It can be useful when the device classification, product code, applicable regulations, or likely premarket path remains uncertain after a careful review of the available information. It is most valuable when the answer can still influence product planning, evidence strategy, timelines, or investment decisions.
Can a 513(g) request replace a Pre-Submission?
No. A 513(g) request and a Pre-Submission serve different purposes. A 513(g) request can help clarify regulatory information, while a Pre-Submission is used to seek FDA feedback on a specific proposed approach. Qualira can help determine which conversation is more useful for the decision your team needs to make.
What information should be ready before preparing a 513(g) request?
The request needs a clear description of the device and the specific regulatory question. Depending on the program, the team may also need to organize intended use, technology, comparable devices, proposed indications, and the facts that make the classification or pathway uncertain. The quality of the question shapes the usefulness of the response.
Can Qualira help after FDA responds?
Yes. The response should be considered alongside the device, intended use, available evidence, product development plan, and commercial goals. Qualira can help translate the information into the next regulatory decision, including whether to refine the strategy, plan a Pre-Submission, prepare for a 510(k), or investigate another route.
TALK WITH QUALIRA